Ziprasidone-induced spontaneous orgasm
Authors:
- 22 January 2009
- journal article
- other
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (6) , 947-948
Abstract
Neuroleptic treatment in schizophrenic patients has been associated with sexual dysfunction, including impotence and decreased libido. Spontaneous ejaculation without sexual arousal during typical antipsychotic treatment is a rare condition that has been described with zuclopentixol, trifluoperazine, and thiothixene. Here, we are reporting a case of spontaneous orgasm with ziprasidone in a bipolar patient. This patient began to repeatedly experience spontaneous sexual arousal and orgasm, which she had never experienced in the past. Ziprasidone might be causing an increase in sexual orgasm by 5-HT2 receptor antagonism, which preclinical evidence suggests that it facilitates dopamine release in the cortex.Keywords
This publication has 13 references indexed in Scilit:
- Spontaneous Orgasm Started with Venlafaxine and Continued with CitalopramThe Canadian Journal of Psychiatry, 2004
- 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine releaseJournal of Neurochemistry, 2001
- 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortexBiological Psychiatry, 2000
- Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trialPsychopharmacology, 1998
- Letters to the EditorThe Canadian Journal of Psychiatry, 1998
- Cyproheptadine Treatment of Sexual Dysfunction Induced by Serotonin Reuptake InhibitorsClinical Neuropharmacology, 1995
- Trazodone and Spontaneous Orgasms in an Elderly Postmenopausal WomanJournal of Clinical Psychopharmacology, 1995
- Ejaculation associated with zuclopenthixolThe British Journal of Psychiatry, 1994
- Fluoxetine and Orgasmic Sexual ExperiencesThe International Journal of Psychiatry in Medicine, 1991
- Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibitionPsychopharmacology, 1989